Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Biomed Pharmacother. 2019 Oct 9;120:109468. doi: 10.1016/j.biopha.2019.109468

Figure 9:

Figure 9:

NO modified cysteine (NO-Cys) may disrupt binding of ATP. (A)The ATP-bound structure (in white) is superimposed with the final solution structure (in blue) of ABCB1 (NO-Cys431) estimated using 400ns of molecular dynamics simulations. ATP is represented by white spheres and the NO modified cysteine (NO-Cys) is by colored spheres. (B) An optimized BCRP structure showing the NO modified cysteines (NO-Cys) in the vicinity of the ATP binding site.